Pharmacology, Toxicology and Pharmaceutical Science
Imidazole Derivative
100%
Chitosan
75%
Nanoparticle
75%
Andrographolide
75%
Colorectal Carcinoma
75%
Cetuximab
75%
Non Small Cell Lung Cancer
61%
Sirtuin
55%
Sirtuin 6
50%
Synapsin I
50%
Transcription Factor Nrf2
50%
Decongestive Agent
50%
Guava
50%
Triple Negative Breast Cancer
50%
Chitosan Nanoparticle
50%
Cytotoxicity
50%
1,2-Dimethylhydrazine
44%
Malignant Neoplasm
35%
Imidazole
33%
Treatment Group
30%
Cross-Sectional Study
25%
Pectin
25%
Histone Deacetylase
16%
Aberrant Crypt Foci
15%
Nanocarrier
15%
Receptor
15%
Colon Carcinoma
15%
Rhinitis
14%
Fourier Transform Infrared Spectroscopy
11%
Epidermal Growth Factor Receptor
10%
Pharmacokinetic
5%
Cytoprotective Agent
5%
Detoxication
5%
Drug Development
5%
Comorbidity
5%
Viability Assay
5%
Binding Site
5%
Acetic Acid Derivative
5%
Western Blot
5%
Cellular Processes
5%
Carcinogenesis
5%
Protein Bcl 2
5%
Cisplatin
5%
Anticarcinogen
5%
Antiinfective Agent
5%
Mortality Rate
5%
Side Effect
5%
IC50
5%
Tumor Suppressor Protein
5%
Medicine and Dentistry
Lung Cancer Cell Line
50%
Non Small Cell Lung Cancer
50%
Sirtuin 6
50%
Synapsin I
50%
Transcription Factor Nrf2
50%
Imidazole Derivative
50%
SIRT6
33%
Antioxidant
22%
Acetic Acid
16%
Reactive Oxygen Species
16%
Homeostasis
16%
Imidazole
16%
Cancer Growth
11%
Redox Signalling
11%
Morphology
11%
Prothrombin
5%
Sirtuin1
5%
Cytoprotective Agent
5%
Cell Viability Assay
5%
Nuclear Factor
5%
Cell Survival
5%
Real-Time Polymerase Chain Reaction
5%
Antioxidant Enzyme
5%
Epigenetic Modification
5%
Histone Deacetylase
5%
Protein Expression
5%
NCI-H460 Cell Line
5%
Transformed Cell
5%
Deacetylation
5%
Sirtuin
5%
Cancer Pathobiology
5%
Detoxication
5%
Biochemistry, Genetics and Molecular Biology
Sirtuin
50%
Transcription Factor Nrf2
25%
Synapsin I
25%
X-Ray Computed Tomography
25%
Histone Deacetylase
16%
Enzyme
16%
Protein Expression
13%
Homeostasis
13%
Gene Expression
11%
Epigenetics
11%
Cancer Cell
11%
Docking (Molecular)
11%
Metabolic Pathway
11%
Absorption
11%
Transcription
5%
Cell Survival
5%
Carcinogenesis
5%
Comorbidity
5%
Pharmacokinetic Properties
5%
Isoform
5%
Dynamics
5%
Western Blot
5%
Protein Data Bank
5%
Binding Site
5%
Reverse Transcription Polymerase Chain Reaction
5%
